NUSAP1 and hepatocellular carcinoma: Extensive research has demonstrated that NUSAP1 is overexpressed in various malignant tumors such as glioma (16), hepatocellular carcinoma (17), gastric cancer (18), lung cancer (19), prostate cancer (20), breast cancer (21), and bladder cancer (22).